Drawing for AMINATURE

USPTO serial 87097728

AMINATURE

Reviewed by CopyMark Law Group

Reg. 5408327Status 702Registered
Filing date
Status date
Registration date
Feb 20, 2018
Examiner
SNABB, SANDRA MARIE
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with AMINATURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Geoffrey D. Aurini

Geoffrey D. Aurini HARNESS, DICKEY & PIERCE, P.L.C.5445 CORPORATE DRIVESUITE 200TROY, MI 48098

Goods and services

ClassDescriptionStatusFirst use
005[ Amino acids for medical or veterinary purposes; Amino acid preparations for veterinary purposes; ] Food supplements consisting of amino acids; Dietary supplements consisting of amino acids; [ Amino acid preparations for medical purposes; ] Dietary supplements consisting of amino acids, minerals and trace elements; Methionine preparations; [ Synthetic peptides for pharmaceutical purposes, namely, the treatment of skin disorders, chemical imbalances, allergies, skin disorders for animals, disorders of the nervous system, disorders of the immune system, disorders of the cardio-vascular system, disorders of the metabolic system, disorders of the respiratory system, disorders of the musculo-skeletal system, disorders of the genitourinary system, inflammatory disorders; synthetic peptides for pharmaceutical purposes, namely, synthetic peptides for the treatment of skin disorders, chemical imbalances, allergies, skin disorders for animals, tumor, cancer, eye diseases and conditions, disorders of the nervous system, disorders of the immune system, disorders of the cardio-vascular system, disorders of the metabolic system, disorders of the respiratory system, disorders of the musculo-skeletal system, disorders of the genitourinary system, inflammatory disorders; Ferments for medical or veterinary use; Food for babies; Vitamin preparations; Pharmaceutical preparations for skin care, appetite suppressants, use in dermatology, treating chemical imbalances, treating allergies, use in chemotherapy, skin care for animals; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; ] Protein dietary supplements; [ Dietary supplements for medical purpose; ] Dietary supplement drinks [ ; Enzymes for medical purposes; Enzyme preparations for medical purposes ]ACTIVEMar 9, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 22, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 22, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 22, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 8, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Feb 20, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 20, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 17, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 16, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 13, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 13, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 28, 2017IUAFUSE AMENDMENT FILED—
Dec 28, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 8, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 13, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 13, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 24, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 9, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 1, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 1, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 1, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 12, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 16, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 16, 2016GNSLLETTER OF SUSPENSION E-MAILED—
Nov 16, 2016CNSLSUSPENSION LETTER WRITTEN—
Nov 16, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Nov 16, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 16, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 16, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 7, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 7, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 3, 2016ALIEASSIGNED TO LIE—
Oct 26, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 18, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2016DOCKASSIGNED TO EXAMINER—
Jul 14, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 12, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance